Liana Moussatos

Phil Nadeau

Arshad Hydra

Biren Amin

Edward Tenthoff

Joseph Giordano

Matthew Kaplan

Matt Kaplan

- XOMA Royalty Corporation entered into a **Common Stock Sales Agreement** with **Leerink Partners LLC** on **October 3, 2025**.  **[791908_0001193125-25-230466_d64736d8k.htm:1]** 
- This agreement allows the company to offer and sell **up to $75,000,000** of its common stock through Leerink.  **[791908_0001193125-25-230466_d64736d8k.htm:1]** **[791908_0001193125-25-230466_d64736dex52.htm:0]** 
- The net proceeds from the common stock offering are intended for **acquiring additional potential royalty and milestone revenue streams, working capital, and other general corporate purposes**.  **[791908_0001193125-25-230466_d64736d8k.htm:1]** 
- Leerink Partners LLC will receive a commission of **up to 3.0%** of the gross proceeds from the common stock sales.  **[791908_0001193125-25-230466_d64736d8k.htm:1]** **[791908_0001193125-25-230466_d64736dex11.htm:59]** 
- Additionally, XOMA Royalty Corporation entered into an agreement with **H.C. Wainwright & Co., LLC** to issue and sell **Depositary Shares**, each representing **1/1000th of a share of 8.375% Series B Cumulative Perpetual Preferred Stock**.  **[791908_0001193125-25-230466_d64736dex12.htm:1]**

XOMA Royalty Corp Enters into Two "At-The-Market" Equity Offering Agreements

- **XOMA Royalty Corporation** completed the **acquisition of HilleVax, Inc.** on **September 17, 2025**, resulting in HilleVax becoming a **wholly owned subsidiary of XOMA**.  **[791908_0001193125-25-213583_d48493d8k.htm:2]** **[791908_0001193125-25-213583_d48493d8k.htm:3]** 
- The acquisition was structured as a **cash tender offer** for HilleVax common stock at **$1.95 per share**, along with **one contingent value right (CVR)** per share.  **[791908_0001193125-25-213583_d48493dex21.htm:2]** 
- The **$1.95 Cash Amount** per share was based on an estimated **Closing Net Cash** of **$102,950,000** for HilleVax as of August 4, 2025.  **[791908_0001193125-25-213583_d48493dex21.htm:2]** 
- Holders of HilleVax's outstanding common stock, restricted stock unit awards, and in-the-money options received CVRs, which represent the right to receive potential future payments.  **[791908_0001193125-25-213583_d48493dex22.htm:0]** **[791908_0001193125-25-213583_d48493dex21.htm:2]** **[791908_0001193125-25-213583_d48493d8k.htm:2]**

XOMA Royalty Corporation Completes Acquisition of HilleVax, Inc.

XOMA Royalty (XOMA)